HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required) | RFA NS 22 023

Opportunity Information: Apply for RFA NS 22 023

The HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (RFA-NS-22-023) is an NIH Pathway to Independence (K99/R00) grant opportunity aimed at helping exceptional postdoctoral researchers move more quickly and successfully into independent, tenure-track (or equivalent) faculty roles. It sits under the NIH HEAL Initiative, which focuses on accelerating scientific solutions to address pain and substance use disorder (SUD). The central goal of this program is workforce development: NIH is trying to grow a strong pipeline of independent investigators who can lead research programs in pain and/or SUD, particularly in areas aligned with HEAL priorities. A key scientific requirement embedded in the title is that the proposed work must include independent basic experimental studies involving humans, meaning the research is expected to include human-based experimental approaches rather than being limited to animal models or purely observational work.

Structurally, this is a phased career transition mechanism. The K99 phase supports a mentored postdoctoral period where the awardee continues advanced training, produces high-impact work, and builds a clear plan for independence under the guidance of established mentors. The R00 phase then provides independent NIH support after the investigator secures an independent faculty position, helping them launch their own lab or research group and establish a distinct, self-directed research program. In practical terms, NIH is using this award to reduce the common gap between postdoctoral training and the first major independent research grant, giving awardees both credibility and financial runway as they transition into independence.

The opportunity is offered as a discretionary NIH grant, and it falls within broad federal assistance categories that include education and health. The listing references multiple CFDA numbers (93.121, 93.213, 93.273, 93.398, 93.846, 93.853, 93.865, 93.866), reflecting NIH’s multi-institute participation and the cross-cutting nature of pain and SUD research. While the notice does not specify an award ceiling or the expected number of awards in the provided text, the program’s intent is clearly to build a cohort of early-career investigators, implying a competitive selection process focused on identifying candidates with strong publication records, compelling transition plans, and research proposals that are well matched to HEAL priorities and the human experimental requirement.

Eligibility for applicant organizations is broad and includes many types of U.S.-based entities that can serve as the host institution for the candidate. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with and without 501(c)(3) status (when they are not institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations. The announcement also explicitly calls out additional eligible applicant categories, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American Tribal Governments (other than federally recognized), and U.S. territories or possessions. Taken together, the eligibility language signals an effort to encourage participation across a wide range of institutional settings, including organizations that serve populations historically underrepresented in biomedical research.

At the same time, there are important limits on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, the opportunity does allow foreign components as defined by the NIH Grants Policy Statement, meaning an otherwise eligible U.S. applicant may include certain defined international elements in the project when well justified and permitted under NIH policy. This distinction matters for applicants considering international collaborations or specialized activities that may require work outside the United States.

The sponsoring agency is the National Institutes of Health, and the opportunity’s original closing date is listed as March 11, 2025. The opportunity was created on December 15, 2022. Overall, this funding announcement is best understood as a targeted NIH career development and launch mechanism: it is meant for high-performing postdoctoral researchers ready to propose a credible, human-focused experimental research program in pain and/or SUD, demonstrate a clear pathway to a faculty appointment, and use the staged K99-to-R00 support to establish a durable independent research trajectory aligned with the HEAL Initiative.

• The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.213, 93.273, 93.398, 93.846, 93.853, 93.865, 93.866.
• This funding opportunity was created on 2022-12-15.
• Applicants must submit their applications by 2025-03-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA NS 22 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: